- Washington, D.C.
Rachel Jenkins’ Bio
Rachel leads Avascent’s healthcare advisory practice where she consults on a wide range of issues faced by companies in the market, including early-stage market entry strategy development, merger and acquisition due diligence, strategic/account planning, and capture support and price-to-win assessment.
Rachel’s areas of expertise include patient care and benefits management, public health and life sciences, and health information technology.
She consults on a wide range of issues faced by companies in the market, including organic market entry and growth strategy development, inorganic strategy development and M&A due diligence, and more tactical strategic account planning and capture support. Rachel has supported a diverse set of clients, from leading healthcare providers and insurers to professional and IT services firms, helping them translate macro market trends, customer requirements, and competitive dynamics into sustainable growth strategies.
Rachel is an active member of the Health Information and Management Systems Society (HIMSS) Federal Health Community and the Professional Services Council (PSC). Prior to joining Avascent, Ms. Jenkins worked with the Markets and Enterprise Program at the World Resources Institute.
She graduated summa cum laude and Phi Beta Kappa from Washington University in St. Louis with a B.A. in international studies.